Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: Implications for the immunologic response to HIV in the female genital tract

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 16, Issue 3, 1997, Pages 161-168

  Sha, Beverly E ^a,d   D'Amico, Ron D ^a   Landay, Alan L ^a   Spear, Gregory T ^a   Massad, L Stewart ^b   Rydman, Robert J ^b   Warner, Ned A ^c   Padnick, Jodi ^a   Ackatz, Lori ^a   Charles, Lesley A ^a   Benson, Constance A ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b Jr Hospital of Cook County   (United States)

^c INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cervicovaginal lavage fluid; Cytokines; Mucosal immunity; Women

Indexed keywords

ANTIBODY; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; SECRETORY IMMUNOGLOBULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; PRIORITY JOURNAL; UTERINE CERVIX DYSPLASIA; VAGINITIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADULT; BIOLOGICAL MARKERS; BODY FLUIDS; CD4 LYMPHOCYTE COUNT; CERVIX UTERI; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; FEMALE; GENITAL DISEASES, FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN A, SECRETORY; MENSTRUAL CYCLE; MIDDLE AGED; VAGINA;

EID: 0030664946     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199711010-00004     Document Type: Review

References (30)

1. Ellerbrock TV, Bush TJ, Chamberland ME, Oxtoby MJ. Epidemiology of women with AIDS in the United States. 1981 through 1990. JAMA 1991;265:2971-5.
2. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 1995. Atlanta: U.S. Department of Health and Human Services, Public Health Service, 1996:7(2).
3. Centers for Disease Control and Prevention. First 500,000 AIDS cases - United States, 1995. MMWR Morbid Mortal Wkly Rep 1996;44:849-53.
4. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991;163:233-9.
5. Moss GB, Clemetson D, D'Costa L, et al. Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi. Kenya. J Infect Dis 1991;164:588-91.
6. Miller CJ, McGhee JR, Gardner MB. Biology of disease: mucosal immunity, HIV transmission, and AIDS. Lab Invest 1992;68:129-45.
7. Mestecky J, Kutteh WH, Jackson S. Mucosal immunity in the female genital tract: relevance to vaccination efforts against the human immunodeficiency virus. AIDS Res Hum Retroviruses 1994;10:S11-S20.
8. Witkin SS Immunology of the vagina. Clin Obstet Gynecol 193;36:122-8.
9. Clemetson DB, Moss GB, Willerford DM, et al. Detection of HIV DNA in cervical and vaginal secretions: prevalence and correlates among women in Nairobi, Kenya. JAMA 1993;269:2860-4.
10. Belec L, Gherardi R, Payan C, et al. Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women. Cytokine 1995;7:568-74.
11. Pomerantz RJ, de la Monte SM, Donegan SP, et al. Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med 1988;108:321-7.
12. Lu XS, Belec L, Pillot. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women. J Infect Dis 1993;167:1189-92.
13. Belec L, Georges AJ, Steenman G, Martin PMV. Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J Infect Dis 1989;160:385-91.
14. Belec L, Dupre T, Prazuck T, et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis 1995;172:691-7.
15. Belec L, Tevi-Benissan C, Lu X-S, Prazuck T, Pillot J. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection. AIDS Res Hum Retroviruses 1995;11:719-29.
16. Spear GT, Sullivan BL, Landay AL, Lint TF. Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis. J Virology 1990;64:5869-73.
17. Sullivan BL, Knopoff EJ, Saifuddin M, et al. Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo. J Immunol 1996;157:1791-8.
18. Pantaleo g, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993;328: 327-35.
19. Poli G, Fauci AS. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Hum Retroviruses 1992;8:191-7.
20. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 1994;170:1597-601.
21. Massad LS, Halperin CJ, Bitterman P. Correlation between colposcopically directed biopsy and cervical loop excision. Gvnecol Oncol 1996;60:400-3.
22. Broder S. The Bethesda system for reporting cervical/vaginal cytologic diagnosis: report of the 1991 Bethesda Workshop. JAMA 1992;267:1892.
23. Gewurz H, Suyehira L, Complement. In: Rose NR, Fiedman H, eds. Manual of clinical immunology, 2nd ed. Washington, DC: American Society of Microbiology, 1980:163-74.
24. Matsuyama T, Kobayashi N, Yamamoto N. Cytokines and HIV infections: is AIDS a tumor necrosis factor disease? AIDS 1991; 5:1405-17.
25. Poli G, Fauci AS. Cytokine modulations of HIV expression. Semin Immunol 1993;5:165-73.
26. Rutanen EM. Cytokines reproduction. Ann Med 1993;25:343-7.
27. Bardeguez AD, Skurnick J, Perez G, Colon J, Kloser P, Grandchamp J, Denny T. Lymphocyte shedding from genital tract of HIV-infected women: immunophenotypic and clinical correlates [abstract We.A.3033]. XIth International Conference on AIDS, Vancouver, July 7-12, 1996.
28. Ghys P, Fransen K, Diallo MO, et al. The association between cervico-vaginal HIV-1 shedding and sexually transmitted disease, immunosuppression, and serum HIV-1 viral load in female sex workers in Abidjan, Côte D'Ivoire [abstract We.C.332]. XIth International Conference on AIDS, Vancouver, July 7-12, 1996.
29. Mostad S, Welch M, Chohan B, et al. Cervical and vaginal HIV-1 DNA shedding in female STD clinic attenders [abstract We.C.333]. XIth International Conference on AIDS, Vancouver, July 7-12, 1996.
30. Robinson W, DaSilva C, Moday H, Saint M, Adams J, Morris CB. Detection of human papilloma virus and human immunodeficiency virus in vaginal washings of HIV infected women [abstract 51]. Society of Gynecologic Oncologists, 28th Annual Meeting, Phoenix, AZ, March 22-26, 1997.